$HEAR
Turtle Beach Corp

2021 Q2 Form 10-Q Financial Statement

#000156459021041696 Filed on August 05, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q4 2020 Q2
Revenue $78.56M $132.9M $79.68M
YoY Change -1.4% 30.61% 92.79%
Cost Of Revenue $49.85M $85.30M $50.45M
YoY Change -1.19% 29.05% 79.17%
Gross Profit $28.71M $47.64M $29.23M
YoY Change -1.77% 33.4% 121.9%
Gross Profit Margin 36.54% 35.84% 36.68%
Selling, General & Admin $23.85M $24.10M $16.27M
YoY Change 46.6% 21.72% 18.37%
% of Gross Profit 83.08% 50.59% 55.66%
Research & Development $4.416M $3.600M $3.001M
YoY Change 47.15% 44.0% 76.53%
% of Gross Profit 15.38% 7.56% 10.27%
Depreciation & Amortization $1.432M $1.280M $1.250M
YoY Change 14.56% -2.29% -3.85%
% of Gross Profit 4.99% 2.69% 4.28%
Operating Expenses $28.27M $27.60M $19.27M
YoY Change 46.69% 24.32% 24.5%
Operating Profit $443.0K $20.04M $9.957M
YoY Change -95.55% 48.31% -531.6%
Interest Expense $73.00K $1.500M -$400.0K
YoY Change -118.25% -600.0% -460.36%
% of Operating Profit 16.48% 7.49% -4.02%
Other Income/Expense, Net $65.00K $600.0K $1.616M
YoY Change -95.98% 100.0% 2208.57%
Pretax Income $435.0K $22.10M $11.49M
YoY Change -96.21% 58.99% -589.35%
Income Tax -$1.300M $5.800M $3.300M
% Of Pretax Income -298.85% 26.24% 28.72%
Net Earnings $1.721M $16.30M $8.204M
YoY Change -79.02% -20.03% -445.72%
Net Earnings / Revenue 2.19% 12.27% 10.3%
Basic Earnings Per Share $0.11 $1.07 $0.56
Diluted Earnings Per Share $0.09 $0.93 $0.51
COMMON SHARES
Basic Shares Outstanding 15.92M 14.58M
Diluted Shares Outstanding 18.33M 16.23M

Balance Sheet

Concept 2021 Q2 2020 Q4 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $56.20M $46.70M $21.20M
YoY Change 165.08% 469.51% 523.53%
Cash & Equivalents $56.20M $46.68M $21.21M
Short-Term Investments
Other Short-Term Assets $19.42M $8.100M $10.20M
YoY Change 90.37% 97.56% 88.89%
Inventory $81.93M $71.30M $44.95M
Prepaid Expenses
Receivables $28.03M $43.87M $37.00M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $185.6M $170.0M $113.4M
YoY Change 63.64% 65.75% 45.97%
LONG-TERM ASSETS
Property, Plant & Equipment $6.917M $6.575M $4.366M
YoY Change 58.43% 65.95% -23.63%
Goodwill $10.69M $8.178M $8.178M
YoY Change 30.67% -3.96% 37.68%
Intangibles $6.442M $5.138M $5.518M
YoY Change 16.75% -14.52% -33.71%
Long-Term Investments
YoY Change
Other Assets $7.806M $7.800M $7.600M
YoY Change 2.71% -8.24% 590.91%
Total Long-Term Assets $37.18M $33.48M $27.10M
YoY Change 37.2% 16.22% 12.27%
TOTAL ASSETS
Total Short-Term Assets $185.6M $170.0M $113.4M
Total Long-Term Assets $37.18M $33.48M $27.10M
Total Assets $222.8M $203.5M $140.5M
YoY Change 58.54% 54.89% 37.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $47.91M $42.53M $41.69M
YoY Change 14.91% 88.93% 88.52%
Accrued Expenses $32.84M $30.50M $24.30M
YoY Change 35.12% 27.62% 23.98%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $80.74M $78.65M $68.03M
YoY Change 18.7% 21.77% 29.41%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $4.989M $5.257M $2.900M
YoY Change 72.03% 63.11% -37.81%
Total Long-Term Liabilities $4.989M $5.257M $2.900M
YoY Change 72.03% 63.11% -37.81%
TOTAL LIABILITIES
Total Short-Term Liabilities $80.74M $78.65M $68.03M
Total Long-Term Liabilities $4.989M $5.257M $2.900M
Total Liabilities $89.06M $87.05M $71.00M
YoY Change 25.44% 28.09% 23.66%
SHAREHOLDERS EQUITY
Retained Earnings -$64.21M -$74.77M
YoY Change -34.13%
Common Stock $16.00K $15.00K
YoY Change 7.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $133.7M $116.4M $69.50M
YoY Change
Total Liabilities & Shareholders Equity $222.8M $203.5M $140.5M
YoY Change 58.54% 54.89% 37.98%

Cashflow Statement

Concept 2021 Q2 2020 Q4 2020 Q2
OPERATING ACTIVITIES
Net Income $1.721M $16.30M $8.204M
YoY Change -79.02% -20.03% -445.72%
Depreciation, Depletion And Amortization $1.432M $1.280M $1.250M
YoY Change 14.56% -2.29% -3.85%
Cash From Operating Activities -$8.642M $18.41M $14.31M
YoY Change -160.39% 52.53% -612.9%
INVESTING ACTIVITIES
Capital Expenditures -$1.036M -$1.740M -$1.410M
YoY Change -26.52% 521.43% 213.33%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$1.036M -$1.740M -$1.410M
YoY Change -26.52% 521.43% -89.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.099M 1.930M -320.0K
YoY Change -755.94% -116.89% -103.43%
NET CHANGE
Cash From Operating Activities -8.642M 18.41M 14.31M
Cash From Investing Activities -1.036M -1.740M -1.410M
Cash From Financing Activities 2.099M 1.930M -320.0K
Net Change In Cash -7.579M 18.60M 12.58M
YoY Change -160.25% 5066.67% -291.48%
FREE CASH FLOW
Cash From Operating Activities -$8.642M $18.41M $14.31M
Capital Expenditures -$1.036M -$1.740M -$1.410M
Free Cash Flow -$7.606M $20.15M $15.72M
YoY Change -148.38% 63.16% -771.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
171617000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
114687000
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
49854000
CY2020Q2 us-gaap Cost Of Revenue
CostOfRevenue
50453000
us-gaap Cost Of Revenue
CostOfRevenue
108052000
us-gaap Cost Of Revenue
CostOfRevenue
74675000
CY2021Q2 us-gaap Gross Profit
GrossProfit
28710000
CY2020Q2 us-gaap Gross Profit
GrossProfit
29227000
us-gaap Gross Profit
GrossProfit
63565000
us-gaap Gross Profit
GrossProfit
40012000
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
15678000
CY2020Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9559000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
27223000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
17207000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8409000
us-gaap Interest Expense
InterestExpense
170000
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8173000
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6710000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-514000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
12039000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
28267000
us-gaap Interest Expense
InterestExpense
252000
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1616000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1419000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
435000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11490000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6111000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1286000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3286000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1480000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1462000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.596
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.011
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.598
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y2M12D
CY2021Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesCurrent
CY2021Q2 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesNoncurrent
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4416000
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3001000
us-gaap Operating Income Loss
OperatingIncomeLoss
4944000
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y9M10D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y6M14D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y6M3D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y9M7D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.005
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
1721000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
8204000
us-gaap Net Income Loss
NetIncomeLoss
10559000
us-gaap Net Income Loss
NetIncomeLoss
4649000
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.56
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.67
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.51
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.58
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15920000
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14581000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15737000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14538000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18329000
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16229000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18204000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15363000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
1721000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
8204000
us-gaap Net Income Loss
NetIncomeLoss
10559000
us-gaap Net Income Loss
NetIncomeLoss
4649000
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
805000
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-113000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
94000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-932000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
805000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-113000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
94000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-932000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2526000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8091000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
10653000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3717000
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
56197000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46681000
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
28025000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6575000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
169976000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6917000
CY2021Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
7047000
CY2021Q2 us-gaap Goodwill
Goodwill
10686000
CY2020Q4 us-gaap Goodwill
Goodwill
8178000
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6442000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5138000
CY2021Q2 us-gaap Other Assets
OtherAssets
6090000
CY2020Q4 us-gaap Other Assets
OtherAssets
6640000
CY2021Q2 us-gaap Assets
Assets
222753000
CY2020Q4 us-gaap Assets
Assets
203453000
CY2021Q2 us-gaap Inventory Net
InventoryNet
81931000
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
19418000
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
47909000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
42529000
CY2021Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
32835000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
36122000
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
80744000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
78651000
CY2021Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3328000
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3146000
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4989000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5257000
CY2021Q2 us-gaap Liabilities
Liabilities
89061000
CY2020Q4 us-gaap Liabilities
Liabilities
87054000
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16065231
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16065231
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15475504
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15475504
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
16000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
15000
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
197207000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
190568000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-64214000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-74773000
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
683000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
589000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
625000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
95000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
43867000
CY2020Q4 us-gaap Inventory Net
InventoryNet
71301000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8127000
CY2021Q2 us-gaap Assets Current
AssetsCurrent
185571000
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
6946000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3727000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-101000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
4053000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
335000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
12448000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5816000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
120858000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
120858000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
108000
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
59983000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
8204000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-113000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
133692000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
116399000
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
222753000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
203453000
us-gaap Net Income Loss
NetIncomeLoss
10559000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1847000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-6850000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3316000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
2500000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3262000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
463000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2799000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-15704000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
85000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-878000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
9516000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
12957000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46681000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8249000
us-gaap Interest Paid Net
InterestPaidNet
88000
us-gaap Interest Paid Net
InterestPaidNet
198000
us-gaap Income Taxes Paid
IncomeTaxesPaid
8041000
us-gaap Income Taxes Paid
IncomeTaxesPaid
44000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
8838000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-711000
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
113000
CY2021Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
215000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
912000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1786000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
127122000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
1721000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
805000
CY2021Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
1000
CY2020Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
1000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
18000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
999000
CY2020Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
60000
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
41000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1406000
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
69461000
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Use of estimates<span style="font-style:normal;">: The preparation of accompanying unaudited consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions about future events. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited consolidated financial statements and reported amounts of revenues and expenses during the reporting period. These estimates may change, as new events occur and additional information is obtained, and will be recognized in the consolidated financial statements in the period in which such changes occur. Future actual results could differ materially from these estimates. </span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The novel coronavirus (“COVID-19”) pandemic has disrupted worldwide economic markets and the extent to which COVID-19 continues to affect the Company’s business, results of operations and financial condition will depend on future developments, which are highly uncertain and difficult to predict. We continue to actively monitor and assess the impact of the pandemic on our business, operations, and financial condition.</p>
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7138000
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
69939000
CY2021Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
81235000
CY2021Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
696000
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1362000
CY2021Q2 us-gaap Inventory Net
InventoryNet
81931000
CY2020Q4 us-gaap Inventory Net
InventoryNet
71301000
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
29395000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
27795000
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22478000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
21220000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6917000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6575000
CY2021Q2 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
13586000
CY2020Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
5166000
CY2021Q2 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
4125000
CY2020Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
5487000
CY2021Q2 hear Accrued Freight Current
AccruedFreightCurrent
3400000
CY2020Q4 hear Accrued Freight Current
AccruedFreightCurrent
3401000
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2848000
CY2021Q2 hear Finite Lived Intangible Assets Foreign Currency Net
FiniteLivedIntangibleAssetsForeignCurrencyNet
37000
CY2021Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
12524000
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6082000
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6442000
CY2020Q4 hear Finite Lived Intangible Assets Foreign Currency Gross
FiniteLivedIntangibleAssetsForeignCurrencyGross
845000
CY2021Q2 hear Accrued Contingent Consideration
AccruedContingentConsideration
1928000
CY2021Q2 hear Accrued Customer Fees
AccruedCustomerFees
1388000
CY2020Q4 hear Accrued Customer Fees
AccruedCustomerFees
1562000
CY2021Q2 hear Accrued Expenses Current
AccruedExpensesCurrent
5560000
CY2020Q4 hear Accrued Expenses Current
AccruedExpensesCurrent
13368000
CY2021Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
32835000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
36122000
CY2021Q2 hear Finite Lived Intangible Assets Foreign Currency Gross
FiniteLivedIntangibleAssetsForeignCurrencyGross
781000
CY2021Q2 hear Finite Lived Intangible Assets Foreign Currency Accumulated Amortization
FiniteLivedIntangibleAssetsForeignCurrencyAccumulatedAmortization
744000
CY2020Q4 hear Finite Lived Intangible Assets Foreign Currency Accumulated Amortization
FiniteLivedIntangibleAssetsForeignCurrencyAccumulatedAmortization
784000
CY2020Q4 hear Finite Lived Intangible Assets Foreign Currency Net
FiniteLivedIntangibleAssetsForeignCurrencyNet
61000
CY2020Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
10540000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5402000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5138000
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
300000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
600000
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-2.956
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1283000
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1041000
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1008000
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
889000
CY2020Q4 us-gaap Goodwill
Goodwill
8178000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
2508000
CY2021Q2 hear Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
1600000
CY2021Q2 us-gaap Goodwill
Goodwill
10686000
CY2020Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
100000
us-gaap Interest Expense Debt
InterestExpenseDebt
300000
CY2021Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
47000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
100000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1286000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3286000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1480000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1462000
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.286
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.123
CY2020Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
813000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.239
CY2021Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1022000
CY2020Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
813000
CY2021Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1022000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1300000
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-2.956
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1500000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.123
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3300000
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.286
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1500000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.239
CY2021Q2 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-1800000
us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-1800000
CY2021Q2 hear Unrecognized Tax Benefits Inclusive Of Interest And Penalties
UnrecognizedTaxBenefitsInclusiveOfInterestAndPenalties
3300000
CY2021Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
800000
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1941000
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1406000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3727000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2405000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
501000
hear Share Based Compensation Arrangement By Share Based Payment Award Options Plan Amendment
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPlanAmendment
975000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
12000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
8000
hear Forfeited Expired Restricted Stock Added Back
ForfeitedExpiredRestrictedStockAddedBack
3000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
979000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2383427
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.85
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
33064942
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
11550
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
27.20
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
376040
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
8.68
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
8380
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
11.64
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2010557
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.80
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
48396166
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1964509
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
7.82
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
47376677
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1004264
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.84
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
25212628
hear Sharebased Compensation Arrangement By Sharebased Payment Award Forfeiture Period After Ending Employment
SharebasedCompensationArrangementBySharebasedPaymentAwardForfeiturePeriodAfterEndingEmployment
P90D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
8600000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
14.89
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1600000
hear Incremental Common Shares Attributable To Dilutive Effect Of Restricted Stock Awards
IncrementalCommonSharesAttributableToDilutiveEffectOfRestrictedStockAwards
469000
CY2021Q2 hear Incremental Common Shares Attributable To Dilutive Effect Of Restricted Stock Awards
IncrementalCommonSharesAttributableToDilutiveEffectOfRestrictedStockAwards
421000
CY2020Q2 hear Incremental Common Shares Attributable To Dilutive Effect Of Restricted Stock Awards
IncrementalCommonSharesAttributableToDilutiveEffectOfRestrictedStockAwards
173000
CY2021Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
550000
CY2020Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
550000
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
550000
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
275000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
1721000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
8204000
us-gaap Net Income Loss
NetIncomeLoss
10559000
us-gaap Net Income Loss
NetIncomeLoss
4649000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15920000
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14581000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15737000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14538000
hear Incremental Common Shares Attributable To Dilutive Effect Of Restricted Stock Awards
IncrementalCommonSharesAttributableToDilutiveEffectOfRestrictedStockAwards
86000
CY2021Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1438000
CY2020Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
926000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1448000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
463000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18329000
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16229000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18204000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15363000
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.56
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.67
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.51
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.58
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
85000
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1051000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1052000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
905000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
78564000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
79680000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
171617000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
114687000
CY2020Q2 hear Number Of Shareholders
NumberOfShareholders
8
CY2020Q3 hear Number Of Motions
NumberOfMotions
2
CY2020Q2 hear Number Of Distributors
NumberOfDistributors
2
CY2020Q3 hear Number Of Companies
NumberOfCompanies
2
CY2020Q3 hear Accounts Receivable Outstanding
AccountsReceivableOutstanding
130000
CY2021Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1118000
CY2020Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
712000
CY2020Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1039000
CY2019Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
743000
CY2021Q2 us-gaap Product Warranty Expense
ProductWarrantyExpense
119000
CY2020Q2 us-gaap Product Warranty Expense
ProductWarrantyExpense
412000
us-gaap Product Warranty Expense
ProductWarrantyExpense
453000
us-gaap Product Warranty Expense
ProductWarrantyExpense
558000
CY2021Q2 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
215000
CY2020Q2 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
311000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
470000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
488000
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5331000
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
747000
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4861000
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
5608000
us-gaap Operating Lease Expense
OperatingLeaseExpense
700000
us-gaap Operating Lease Payments
OperatingLeasePayments
600000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
558000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
851000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
732000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
741000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
711000
CY2021Q2 hear Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
2968000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
6561000
CY2021Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
953000
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
5608000

Files In Submission

Name View Source Status
0001564590-21-041696-index-headers.html Edgar Link pending
0001564590-21-041696-index.html Edgar Link pending
0001564590-21-041696.txt Edgar Link pending
0001564590-21-041696-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g2hinrfrtbrs000001.jpg Edgar Link pending
hear-10q_20210630.htm Edgar Link pending
hear-10q_20210630_htm.xml Edgar Link completed
hear-20210630.xsd Edgar Link pending
hear-20210630_cal.xml Edgar Link unprocessable
hear-20210630_def.xml Edgar Link unprocessable
hear-20210630_lab.xml Edgar Link unprocessable
hear-20210630_pre.xml Edgar Link unprocessable
hear-ex311_6.htm Edgar Link pending
hear-ex312_7.htm Edgar Link pending
hear-ex321_8.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending